{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:52:09Z","timestamp":1776880329790,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijtb.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:09:23Z","timestamp":1749236963000},"page":"170-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of treatment interruption with sputum conversion and outcomes in drug-sensitive and drug-resistant tuberculosis patients enrolled under NTEP-a prospective study from 3 centers in South Delhi, Delhi, India"],"prefix":"10.1016","volume":"73","author":[{"given":"Lokender","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Umer","family":"Khayyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijtb.2025.06.006_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12879-022-07078-y","article-title":"The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India","volume":"22","author":"Arentz","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.ijtb.2025.06.006_bib3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1592\/phco.29.12.1468","article-title":"Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists","volume":"29","author":"Hall","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.ijtb.2025.06.006_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01522-2019","article-title":"Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report","volume":"54","author":"Borisov","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijtb.2025.06.006_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijid.2019.03.036","article-title":"Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study","volume":"83","author":"Akkerman","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56553-1","article-title":"Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia","volume":"9","author":"Tola","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ijtb.2025.06.006_bib8","first-page":"219","article-title":"Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaound\u00e9, Cameroon","volume":"86","author":"Kuaban","year":"2009","journal-title":"East Afr Med J"},{"issue":"3","key":"10.1016\/j.ijtb.2025.06.006_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0974-777X.68533","article-title":"Time of default in tuberculosis patients on directly observed treatment","volume":"2","author":"Pardeshi","year":"2010","journal-title":"J Global Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.006_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41598-021-04742-2","article-title":"Risk factors for early TB treatment interruption among newly diagnosed patients in Malaysia","volume":"12","author":"Suliman","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ijtb.2025.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045724","article-title":"The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study","volume":"7","author":"Marx","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2025.06.006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-1","article-title":"Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis","volume":"11","author":"Nahid","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.ijtb.2025.06.006_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/infdis\/jiu551","article-title":"Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia","volume":"211","author":"Bastard","year":"2015","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2025.06.006_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijmyco.2013.08.002","article-title":"Sputum smear positivity at two months in previously untreated pulmonary tuberculosis patients","volume":"2","author":"Singla","year":"2013","journal-title":"Int J Mycobacteriol"},{"issue":"4","key":"10.1016\/j.ijtb.2025.06.006_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00124784-200507000-00017","article-title":"Factors associated with tuberculosis treatment interruption in New York City","volume":"11","author":"Driver","year":"2005","journal-title":"J Publ Health Manag Pract"},{"key":"10.1016\/j.ijtb.2025.06.006_bib17","unstructured":"Central TB Division. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. TB India 2018 status report.Available from: https:\/\/tbcindia.gov.in\/index1.php?lang=1&level=1&sublinkid=4160&lid=2807."},{"key":"10.1016\/j.ijtb.2025.06.006_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2746-5","article-title":"Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients","author":"Atif","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.06.006_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0970-0218.40886","article-title":"An analysis of failure of category II DOTS therapy","volume":"33","author":"Katiyar","year":"2008","journal-title":"Indian J Community Med"},{"issue":"6","key":"10.1016\/j.ijtb.2025.06.006_bib20","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18203\/2320-6012.ijrms20172122","article-title":"Analysis of treatment outcome in multi-drug resistant tuberculosis patients treated under programmatic conditions","volume":"5","author":"Janmeja","year":"2017","journal-title":"International Journal of Research in Medical Sciences"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.006_bib21","first-page":"58","article-title":"Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment","volume":"7","author":"Singla","year":"2003","journal-title":"Int J Tubercul Lung Dis"},{"issue":"7","key":"10.1016\/j.ijtb.2025.06.006_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070064","article-title":"Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes","volume":"8","author":"Podewils","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2025.06.006_bib23","series-title":"Treatment of Tuberculosis: Guidelines for National Programmes","year":"2003"},{"key":"10.1016\/j.ijtb.2025.06.006_bib24","year":"2000","journal-title":"Guidelines for Establishing DOTS Plus Pilot Projects for the Management of Multidrug-Resistant Tuberculosis (MDR-TB)"},{"key":"10.1016\/j.ijtb.2025.06.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-1","article-title":"Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis","volume":"11","author":"Nahid","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijtb.2025.06.006_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2458-7-134","article-title":"Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study","volume":"7","author":"Vree","year":"2007","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.ijtb.2025.06.006_bib27","first-page":"363","article-title":"Health care utilization and costs of a support program for patients living with the human immunodeficiency virus and tuberculosis in Peru","volume":"15","author":"Cerda","year":"2011","journal-title":"Int J Tubercul Lung Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2025.06.006_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5588\/ijtld.12.0133","article-title":"Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis","volume":"17","author":"Pettit","year":"2013","journal-title":"Int J Tubercul Lung Dis"},{"issue":"7","key":"10.1016\/j.ijtb.2025.06.006_bib29","first-page":"2619","article-title":"Study of various causes of defaulter among tuberculosis patients under revised national tuberculosis control programme: a prospective analysis of 5235 tuberculosis patients","volume":"4","author":"Bhadke","year":"2017","journal-title":"International Journal of Research in Medical Sciences, [S.l.]"},{"key":"10.1016\/j.ijtb.2025.06.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2017.27.1.11119","article-title":"Patient attitudes towards community-based tuberculosis DOT and adherence to treatment in an urban setting; Kampala, Uganda","volume":"27","author":"Hassard","year":"2017","journal-title":"Pan Afr Med J."},{"key":"10.1016\/j.ijtb.2025.06.006_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2458-10-72","article-title":"TB treatment initiation and adherence in a South African community influenced more by perceptions than by knowledge of tuberculosis","volume":"10","author":"Cramm","year":"2010","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.ijtb.2025.06.006_bib32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.5588\/ijtld.12.0129","article-title":"Grading of a positive sputum smear and the risk of mycobacterium tuberculosis transmission","volume":"16","author":"Lohmann","year":"2012","journal-title":"Int J Tubercul Lung Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2025.06.006_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/jfmpc.jfmpc_24_16","article-title":"Sputum smear grading and treatment outcome among directly observed treatment-short course patients of tuberculosis unit, Jagdalpur, Bastar","volume":"6","author":"Brahmapurkar","year":"2017","journal-title":"J Fam Med Prim Care"},{"issue":"10","key":"10.1016\/j.ijtb.2025.06.006_bib34","first-page":"JC05","article-title":"Smear conversion, treatment outcomes and the time of default in registered tuberculosis patients on RNTCP DOTS in puducherry, southern India","volume":"8","author":"Vasudevan","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.006_bib35","first-page":"11","article-title":"Reasons for interruption of anti-tubercular treatment as reported by patients with tuberculosis admitted in a tertiary care institute","volume":"58","author":"Gupta","year":"2011","journal-title":"Indian J Tubercul"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:04:27Z","timestamp":1776877467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570725001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0019570725001325"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.06.006","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of treatment interruption with sputum conversion and outcomes in drug-sensitive and drug-resistant tuberculosis patients enrolled under NTEP-a prospective study from 3 centers in South Delhi, Delhi, India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}